O. Cornely

Publications651
h-index80
Citations27,763
Highly Influential Citations818
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • J. Meis
  • 768 Publications • 35,262 Citations
  • T. Walsh
  • 1,106 Publications • 89,167 Citations
  • D. Kontoyiannis
  • 781 Publications • 46,887 Citations
  • D. Denning
  • 831 Publications • 66,238 Citations
  • Publications
  • Influence
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
TLDR
In patients undergoing chemotherapy for acute myelogenous leukemia or the myelodysplastic syndrome, posaconazoles prevented invasive fungal infections more effectively than did either fluconazole or itraconazole and improved overall survival.
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
TLDR
This part of the EFISG guidelines focuses on non-neutropenic adult patients, and liposomal amphotericin B and voriconazole are supported with moderate, and fluconazole with marginal strength for the targeted initial treatment of candidaemia.
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
TLDR
Caspofungin is as effective as and generally better tolerated than liposomal amphotericin B when given as empirical antifungal therapy in patients with persistent fever and neutropenia.
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update
TLDR
The goal of this paper is to summarize the new proposals from ECIL 3, based on the results of studies published after the ECIL 2 meeting, and the prophylactic recommendations for hematopoietic stem cell transplant recipients were formulated differently.
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research…
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.
TLDR
These European Society for Clinical Microbiology and Infectious Diseases and European Confederation of Medical Mycology Joint Clinical Guidelines focus on the diagnosis and management of mucormycosis and strongly recommend continuing treatment until complete response demonstrated on imaging and permanent reversal of predisposing factors.
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial.
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.
TLDR
Recommendations about the microbiological investigation and detection of invasive infection were made and current knowledge on the most appropriate antifungal and supportive treatment was reviewed.
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
...
1
2
3
4
5
...